Zinc finger protein 713 (ZNF713)

Zinc finger protein 713 (ZNF713) is a member of the large and diverse family of zinc finger proteins, primarily characterized by the presence of C2H2-type zinc finger domains[1][2][3]. These proteins function as transcription factors and play central roles in regulating gene expression by binding sequence-specific regions of DNA, often acting as transcriptional enhancers or repressors[1][2][3]. Like other C2H2 zinc finger proteins, ZNF713 is expected to participate in a wide range of biological processes, including the control of cell fate decisions, cell differentiation, transcriptional regulation, apoptosis, immune response, and potentially post-transcriptional regulation through RNA binding[1][2][3]. While the broader family of zinc finger proteins is implicated in diverse physiological and pathological processes—such as oncogenesis, neurodegeneration, and regulation of the immune system—specific functional or disease roles for Zinc finger protein 713 itself have not been well established in the current literature. There are currently no known drugs that specifically target ZNF713, and validated use as a biomarker or known class-specific safety concerns are also not described in the literature[1][2][3]. The function and roles of many individual zinc finger proteins—including ZNF713—remain to be thoroughly characterized. Existing knowledge about ZNF713 is extrapolated primarily from the general properties of the zinc finger protein family.

Other names

FLJ39963ZNF713